Last reviewed · How we verify

NCT06011031

Assessment of Novaloc and Locator Attachment Systems

Status unknown NA Last updated 1 February 2024
What this trial tests

NA trial testing Novaloc attachment in Completely Edentulous Maxilla in 14 participants. Status unknown.

Timeline
5 June 2021
Primary endpoint
5 December 2024
5 December 2024

Quick facts

Lead sponsorAin Shams University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment14
Start date5 June 2021
Primary completion5 December 2024
Estimated completion5 December 2024
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Ain Shams University

Who can join

Adults 30 to 70, any sex, with Completely Edentulous Maxilla. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the current study is to assess the effect of two types of attachments (Locator, Novaloc) on the supporting structures both mechanically using stress strain analysis and biologically through measuring bone height using cbct.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Novaloc attachment

Trials testing the same drug.

Other Ain Shams University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06011031.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing